Cellares Appoints Ossama Eissa as COO to Scale Global Cell Therapy Manufacturing
Slice of Healthcare Team
Nov 15, 2024
Key Highlights
- Ossama Eissa joins Cellares as COO to expand global cell therapy manufacturing.
- Eissa brings over 20 years of experience from Novartis, Lonza, and Legend Biotech.
- Cellares’ IDMO Smart Factories to increase production and accessibility of cell therapies.
- Cellares’ Cell Shuttle™ and Cell Q™ platforms enhance manufacturing and quality control.
- Global expansion targets U.S., Europe, Japan, and beyond to meet cell therapy demand.
Source: Business Wire
Notable Quotes
“ Joining Cellares is an opportunity to address one of the biggest challenges in healthcare today: making cell therapies accessible to all of those who need them. ”
Ossama Eissa, COO at Cellares
“ With Ossama's leadership, we are scaling worldwide production while redefining how cell therapies are made — faster, more reliably, and at scale. ”
Fabian Gerlinghaus, Co-founder and CEO at Cellares
